Industry’ is listed as a postgraduate competence
(‘capacidade’).
Sweden
There is a 2-year diploma course in pharmaceutical
medicine given at the Karolinska Institute and the
Medical Products Agency, Stockholm, organized
for pharmaceutical physicians in conjunction with
the Swedish Board of Pharmaceutical Medicine.
Germany
There is a Diploma in Pharmaceutical Medicine
in Germany which is provided by the DGPharMed
(German Society for Pharmaceutical Medicine).
Since 2005, the University of Essen-Duisburg
has offered a 2-year course leading to a Master of
Science in pharmaceutical medicine. The course
has 450 hours of teaching in 18 modules and a
further 1350 hours are planned for homework.
The last six months are needed for preparation of
a thesis, its presentation and oral examination.
Although only recently available, this course has
longer heritage, having being transferred from the
University of Witten-Herdecke, which since 1997
offered a course leading to a Diploma in Pharma-
ceutical Medicine.
Italy
In pharmaceutical medicine, efforts are being
made to establish a diploma course at the Univer-
sity of Pisa supported by the Italian Association of
Pharmaceutical Physicians (SSFA).
Non-European
Mexico
Mexico granted pharmaceutical medicine special-
ity status in 1999. There is a 2-year specialist
training programme organized by the National
Polytechnic Institute, Faculty of Medicine, Post-
graduate Studies Section, leading to a specialist
qualification in Pharmaceutical Medicine. There
is an entry examination to the programme, which
then includes 17 subjects (84 credits) over four
semesters. There are practical rotations through
pharmaceutical industry departments in the fourth
semester.
Argentina
The University of Buenos Aires offers a postgrad-
uate education programme in pharmaceutical med-
icine, comprising 420 teaching hours and 240
practice hours.
Brazil
The Federal University of Sao Paulo offers a
postgraduate course in pharmaceutical medicine
comprising 200 teaching hours and 160 practice
hours.
Acknowledgements
The authors wish to thank Gareth Hayes, Dr
Ibrahim Farr and Drs Herman Lahon and Juan
Lahuerta of the Council for Education in Pharma-
ceutical Medicine for their contributions and
advice.
References
Centre for Medicines Research. 1996.UK Pharmaceu-
tical R & D expenditure 1982– 1986. Monograph,
London.
Stonier PD, Hayes G. 2003. InCareers with the Phar-
maceutical Industry, Stonier PD (ed.). John Wiley &
Sons, Ltd: Chichester.
Taylor JB. 1993. InTextbook of Pharmaceutical Med-
icine, D’Arcy RF,et al. (eds.). Queen’s University:
Belfast.
Erast & Young. 2001.Biotechnology Annual Report:
http://www.ey.com.
Pharmaceutical Research Manufacturers Association.
1997.PhRMA Annual Report 1999–2000.Mono-
graph. Washington, DC: http://www.phrma.org.
REFERENCES 23